OncoCyte Corp
NASDAQ:OCX

Watchlist Manager
OncoCyte Corp Logo
OncoCyte Corp
NASDAQ:OCX
Watchlist
Price: 2.21 USD 0.91%
Market Cap: 37.2m USD
Have any thoughts about
OncoCyte Corp?
Write Note

Balance Sheet

Balance Sheet Decomposition
OncoCyte Corp

Current Assets 4.8m
Cash & Short-Term Investments 3.4m
Receivables 209k
Other Current Assets 1.2m
Non-Current Assets 65.4m
PP&E 6.5m
Intangibles 56.5m
Other Non-Current Assets 2.4m
Current Liabilities 9.1m
Accounts Payable 872k
Accrued Liabilities 7.9m
Other Current Liabilities 364k
Non-Current Liabilities 51.4m
Long-Term Debt 653k
Other Non-Current Liabilities 50.8m

Balance Sheet
OncoCyte Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
0
8
10
8
8
22
7
36
20
9
Cash Equivalents
0
8
10
8
8
22
7
36
20
9
Short-Term Investments
3
3
2
1
0
0
1
1
0
0
Total Receivables
0
0
0
0
0
0
0
2
2
0
Accounts Receivables
0
0
0
0
0
0
0
1
2
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
0
0
0
1
1
1
3
1
Total Current Assets
4
11
13
9
9
23
9
39
26
11
PP&E Net
0
1
1
1
1
4
7
9
11
5
PP&E Gross
0
1
1
1
1
4
7
9
11
5
Accumulated Depreciation
0
0
0
1
1
0
1
3
4
6
Intangible Assets
2
1
1
1
0
0
15
91
62
57
Goodwill
0
0
0
0
0
0
9
19
0
0
Long-Term Investments
0
0
0
0
0
11
13
0
0
0
Other Long-Term Assets
0
0
0
0
0
2
2
2
2
2
Other Assets
0
0
0
0
0
0
9
19
0
0
Total Assets
5
N/A
13
+144%
14
+13%
10
-29%
10
-7%
40
+320%
55
+39%
160
+188%
100
-37%
75
-25%
Liabilities
Accounts Payable
0
0
0
0
0
1
0
2
1
1
Accrued Liabilities
0
1
1
1
2
3
5
10
9
6
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
1
1
1
3
1
0
0
Other Current Liabilities
6
1
3
2
2
0
1
0
2
0
Total Current Liabilities
6
2
4
5
6
4
9
14
12
7
Long-Term Debt
0
0
0
1
1
2
2
0
0
0
Other Liabilities
0
0
0
0
0
3
11
80
48
42
Total Liabilities
6
N/A
2
-63%
5
+100%
6
+26%
6
+5%
9
+48%
22
+143%
94
+331%
61
-36%
49
-19%
Equity
Common Stock
15
35
46
60
75
125
157
253
300
315
Retained Earnings
15
24
35
55
71
94
124
188
261
290
Other Equity
1
0
1
1
0
0
0
0
0
0
Total Equity
1
N/A
10
N/A
10
-5%
4
-56%
3
-23%
31
+806%
34
+9%
65
+95%
40
-39%
26
-35%
Total Liabilities & Equity
5
N/A
13
+144%
14
+13%
10
-29%
10
-7%
40
+320%
55
+39%
160
+188%
100
-37%
75
-25%
Shares Outstanding
Common Shares Outstanding
1
1
1
2
2
3
4
5
6
8
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Discover More